Recent

% | $
Quotes you view appear here for quick access.

AVEO Pharmaceuticals, Inc. Message Board

  • americanbullybear americanbullybear May 8, 2013 3:55 PM Flag

    shorties beware

    any SNIFF of good news and/or positive comments sends AVEO well over $3...wayyyyyyyyyyy oversold.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Total Cash Per Share $$$$ 3.88

    • This looks like a good joint patent between aveo and xoma.

      United States Patent 8,273,355
      Winston, Jr. , et al. September 25, 2012

      Hepatocyte growth factor (HGF) binding proteins
      Abstract
      The present invention provides a family of binding proteins that bind and neutralize the activity of hepatocyte growth factor (HGF), in particular human HGF. The binding proteins can be used as diagnostic and/or therapeutic agents. With regard to their therapeutic activity, the binding proteins can be used to treat certain HGF responsive disorders, for example, certain HGF responsive tumors.

      Inventors: Winston, Jr.; William M. (Marlborough, MA), Wright; S. Kirk (Waltham, MA), Han; May (Brookline, MA), Breault; Lyne (Roslindale, MA), Lin; Jie (West Roxbury, MA), Etemad-Gilbertson; Bijan (Jamaica Plain, MA), Knuehl; Christine (Natick, MA), Gyuris; Jeno (Lincoln, MA), Horwitz; Arnold (San Leandro, CA)
      Assignee: AVEO Pharmaceuticals, Inc. (Cambridge, MA)

      XOMA Technology Ltd. (Berkeley, CA)

 
AVEO
0.93-0.0350(-3.63%)Apr 29 3:59 PMEDT